2026-01-28 - Analysis Report
**Company Overview:** Texas Instruments is a technology company that designs and manufactures semiconductors and other electronic components.

**Return Comparison**
**TXN (Texas Instruments) vs S&P 500 (VOO)**

- Cumulative Return of TXN: 93.79%
- Cumulative Return of VOO: 128.51%
- Divergence: -33.80 (relative divergence: 26.30%)

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap (B)    |
|------------|------|------|-------|------|-------------|
| 2016-2018  | 25.0% | 20.6% | 17.0% | 1.2    | 85.9B       |
| 2017-2019  | 36.0% | 20.6% | 11.0% | 1.4    | 116.6B      |
| 2018-2020  | 35.0% | 28.7% | 11.0% | 1.1    | 149.2B      |
| 2019-2021  | 73.0% | 28.7% | 9.0%  | 1.2    | 171.3B      |
| 2020-2022  | 21.0% | 28.7% | 16.0% | 1.1    | 150.2B      |
| 2021-2023  | -25.0% | 21.7% | -43.0%| 1.2    | 155.0B      |
| 2022-2024  | -11.0% | 21.7% | -40.0%| 1.1    | 170.5B      |
| 2023-2025  | -16.0% | 31.9% | -91.0%| 1.3    | 157.7B      |

**Recent Stock Price Fluctuations**
- Close: $196.63
- Last-Market: +$0.02
- 5-day SMA: $195.19
- 20-day SMA: $187.66
- 60-day SMA: $175.16

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**
- Market Risk Indicator (MRI): 0.70 (Medium Risk Investment)
- RSI: 56.14
- PPO: 0.19
- Recent relative divergence change: 3.30 (improving)
- Expected Return (%): 16.30%
- Expected excess return compared to S&P 500 if invested long-term: 16.30%

**News & Significant Events**
- 2026-01-27: Texas Instruments guides above Q1 estimates after roughly in-line Q4 results
- 2026-01-27: Texas Instruments rises as Q1 guidance tops expectations at midpoint
- 2026-01-27: Stocks making the biggest moves after hours: Texas Instruments, Seagate Technology, Qorvo, and more
- 2026-01-27: Texas Instruments perks up amid Q4 results, guidance (TXN:NASDAQ)
- 2026-01-27: Texas Instruments (TXN) Q4 2025 earnings results miss EPS estimates with inline revenue

**Analyst Opinions**
- Key: Hold
- Mean (1=StrongBuy~5=Sell): 2.58
- Opinions: 33
- Target Price (avg/high/low): $194.98 / $245.00 / $140.00

**Recent Earnings Analysis**
| Date | EPS | Revenue         |
|------|-----|-----------------|
| 2025-10-23 | $1.49 | $4.74 B$        |
| 2025-07-29 | $1.42 | $4.45 B$        |
| 2025-04-24 | $1.29 | $4.07 B$        |
| 2024-10-23 | $1.48 | $4.15 B$ (2025-10-23 same)    |

**Revenue and Profitability**
| Quarter     | Revenue | Profit Margin |
|-------------|---------|---------------|
| 2025-09-30  | $4.74B  | 57.42%        |
| 2025-06-30  | $4.45B  | 57.89%        |
| 2025-03-31  | $4.07B  | 56.84%        |
| 2024-12-31 | $4.01B  | 57.75%        |
| 2024-09-30 | $4.15B  | 59.60%        |

**Capital and Profitability**
| Quarter     | Equity   | ROE |
|-------------|-----------|------|
| 2025-09-30  | $16.63B | 8.20% |
| 2025-06-30  | $16.40B | 7.89% |
| 2025-03-31  | $16.41B | 7.19% |
| 2024-12-31 | $16.90B | 7.13% |
| 2024-09-30 | $17.27B | 7.89% |

**Comprehensive Analysis**

TXN has a moderate return on investment with a 93.79% cumulative return compared to the S&P 500's 128.51%. The Alpha, Beta analysis shows the company had a volatile performance with the CAGR ranging from 25.0% to -25.0%, and the Beta value has fluctuated between 1.1 and 1.4. The recent stock price has been stable, with the close price being $196.63. The RSI and PPO index indicators indicate a moderate risk investment, and the expected return compared to the S&P 500 is 16.30%. The news suggests Texas Instruments guides above Q1 estimates after roughly in-line Q4 results and is expected to perk up amid Q4 results and guidance. The analyst opinions are largely neutral, with a mean rating of 2.58 and a target price of $194.98. The recent earnings analysis shows a moderate growth in EPS and revenue. The financial information reveals a moderate profit margin and ROE, with a fluctuating equity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.